An Interaction between Glutathione and the Capsid Is Required for the Morphogenesis of C-Cluster Enteroviruses

Glutathione (GSH) is the most abundant cellular thiol playing an essential role in preserving a reduced cellular environment. Cellular GSH levels can be efficiently reduced by the GSH biosynthesis inhibitor, L-buthionine sulfoximine (BSO). The aim of our study was to determine the role of GSH in the growth of two C-cluster enteroviruses, poliovirus type 1 (PV1) and coxsackievirus A20 (CAV20). Our results show that the growth of both PV1 and CAV20 is strongly inhibited by BSO and can be partially reversed by the addition of GSH. BSO has no effect on viral protein synthesis or RNA replication but it strikingly reduces the accumulation of 14S pentamers in infected cells. GSH-pull down assays show that GSH directly interacts with capsid precursors and mature virus made in the absence of BSO whereas capsid precursors produced under GSH-depletion do not bind to GSH. In particular, the loss of binding of GSH may debilitate the stability of 14S pentamers, resulting in their failure to assemble into mature virus. Immunofluorescence cell imaging demonstrated that GSH-depletion did not affect the localization of viral capsid proteins to the replication complex. PV1 BSO resistant (BSOr) mutants evolved readily during passaging of the virus in the presence of BSO. Structural analyses revealed that the BSOr mutations, mapping to VP1 and VP3 capsid proteins, are primarily located at protomer/protomer interfaces. BSOr mutations might, in place of GSH, aid the stability of 14S particles that is required for virion maturation. Our observation that BSOr mutants are more heat resistant and need less GSH than wt virus to be protected from heat inactivation suggests that they possess a more stable capsid. We propose that the role of GSH during enterovirus morphogenesis is to stabilize capsid structures by direct interaction with capsid proteins both during and after the formation of mature virus particles.

[1]  D. Filman,et al.  Cryo-Electron Microscopy Reconstruction Shows Poliovirus 135S Particles Poised for Membrane Interaction and RNA Release , 2013, Journal of Virology.

[2]  A. Corti,et al.  Gamma-glutamyltransferase, H2O2-induced apoptosis and expression of catalase. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  Milton W. Taylor,et al.  In Vitro Assembly of an Empty Picornavirus Capsid follows a Dodecahedral Path , 2012, Journal of Virology.

[4]  A. Paul,et al.  Alanine Scanning of Poliovirus 2CATPase Reveals New Genetic Evidence that Capsid Protein/2CATPase Interactions Are Essential for Morphogenesis , 2012, Journal of Virology.

[5]  R. Purcell,et al.  Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis , 2011, Journal of Virology.

[6]  Ping Jiang,et al.  Direct Interaction between Two Viral Proteins, the Nonstructural Protein 2CATPase and the Capsid Protein VP3, Is Required for Enterovirus Morphogenesis , 2010, PLoS pathogens.

[7]  Wei Chen,et al.  Inhibitory effects of glutathione on dengue virus production. , 2010, Biochemical and biophysical research communications.

[8]  James M. Hogle,et al.  Catching a Virus in the Act of RNA Release: a Novel Poliovirus Uncoating Intermediate Characterized by Cryo-Electron Microscopy , 2010, Journal of Virology.

[9]  A. Paul,et al.  Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication , 2007, Proceedings of the National Academy of Sciences.

[10]  M. Vignuzzi,et al.  Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. , 2007, Genes & development.

[11]  H. Dawson,et al.  Glutathione is required for efficient production of infectious picornavirus virions. , 2006, Virology.

[12]  M. Pallansch,et al.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication. , 2005, Annual review of microbiology.

[13]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[14]  A. Nakane,et al.  Buthionine sulfoximine inhibits cytopathic effect and apoptosis induced by infection with human echovirus 9 , 2004, Archives of Virology.

[15]  Dean P. Jones,et al.  Inhibition of influenza infection by glutathione. , 2003, Free radical biology & medicine.

[16]  E. Wimmer,et al.  Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA. , 2000, The Journal of general virology.

[17]  B L Trus,et al.  Three-dimensional structure of poliovirus receptor bound to poliovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Palamara,et al.  Increased replication of Sendai virus in morphine-treated epithelial cells: evidence for the involvement of the intracellular levels of glutathione. , 1999, International journal of immunopharmacology.

[19]  E. Wimmer,et al.  Characterization of the Nucleoside Triphosphatase Activity of Poliovirus Protein 2C Reveals a Mechanism by Which Guanidine Inhibits Poliovirus Replication* , 1999, The Journal of Biological Chemistry.

[20]  A. Palamara,et al.  Intracellular GSH content and HIV replication in human macrophages , 1997, Journal of leukocyte biology.

[21]  R. Rueckert.  Picornaviridae: The viruses and their replication , 1996 .

[22]  A. Palamara,et al.  Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. , 1995, Antiviral research.

[23]  K. Kirkegaard,et al.  Copyright � 1995, American Society for Microbiology RNA Binding Properties of Poliovirus Subviral Particles , 1994 .

[24]  C. Morrow,et al.  Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles , 1992, Journal of virology.

[25]  A. Paul,et al.  Cell-free, de novo synthesis of poliovirus. , 1991, Science.

[26]  P. Minor,et al.  An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain , 1991, Journal of virology.

[27]  N. Moscufo,et al.  Myristoylation is important at multiple stages in poliovirus assembly , 1991, Journal of virology.

[28]  D. Marc,et al.  Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles , 1990, Journal of virology.

[29]  B. Semler,et al.  Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. , 1988, Virology.

[30]  E. Wimmer,et al.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[32]  S. Kuge,et al.  Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. A. Phillips,et al.  Differences between poliovirus empty capsids formed in vivo and those formed in vitro: a role for the morphopoietic factor , 1981, Journal of virology.

[34]  B. A. Phillips,et al.  Picornaviral structure and assembly. , 1981, Microbiological reviews.

[35]  H. Eggers,et al.  Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. , 1979, Virology.

[36]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.

[37]  B. A. Phillips,et al.  In vitro assembly of poliovirus. V. Evidence that the self-assembly activity of 14 S particles is independent of extract assembly factor(s) and host proteins. , 1978, Virology.

[38]  K. Lonberg-Holm,et al.  Early alteration of poliovirus in infected cells and its specific inhibition. , 1975, The Journal of general virology.

[39]  M. Breindl.  The structure of heated poliovirus particles. , 1971, The Journal of general virology.

[40]  B. A. Phillips.  In vitro assembly of polioviruses. I. Kinetics of the assembly of empty capsids and the role of extracts from infected cells. , 1969, Virology.

[41]  P. Cooper,et al.  Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles. , 1962, Virology.

[42]  V. Racaniello.  Picornaviridae : the viruses and their replication , 2001 .

[43]  K. Bienz,et al.  Poliovirus subviral particles associated with progeny RNA in the replication complex. , 1995, The Journal of general virology.

[44]  E. Wimmer,et al.  Genetics of poliovirus. , 1993, Annual review of genetics.

[45]  B. Rombaut,et al.  The proteins of poliovirus. , 1992, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.